title: Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors.
authors.affiliation: Medical Oncology Department, National Institute for Cancer Research, Genoa, Italy. claudia.bighin@istge.it
authors.forename: Claudia
authors.initials: C
authors.lastname: Bighin
authors.forename: Gianluigi
authors.initials: G
authors.lastname: Lunardi
authors.forename: Lucia
authors.initials: L
authors.lastname: Del Mastro
authors.forename: Paola
authors.initials: P
authors.lastname: Marroni
authors.forename: Paola
authors.initials: P
authors.lastname: Taveggia
authors.forename: Alessia
authors.initials: A
authors.lastname: Levaggi
authors.forename: Sara
authors.initials: S
authors.lastname: Giraudi
authors.forename: Paolo
authors.initials: P
authors.lastname: Pronzato
mesh_terms: D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D018567:Breast Neoplasms, Male / Q000097:blood* / Q000188:drug therapy*; D004970:Estrone / Q000031:analogs & derivatives* / Q000097:blood; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013739:Testosterone / Q000097:blood*
chemical_list: D047072:Aromatase Inhibitors; D004970:Estrone; D013739:Testosterone; D005640:Follicle Stimulating Hormone; C017296:estrone sulfate